The charts on this page feature a breakdown of the total annual pay for the top executives at VARIAN MEDICAL SYSTEMS INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. VARIAN MEDICAL SYSTEMS INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. VARIAN MEDICAL SYSTEMS INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Dow R. Wilson
President and Chief Executive Officer
Total Cash $2,403,500 Equity $7,000,016 Other $42,780 Total Compensation $9,446,296
John W. Kuo
Senior Vice President, General Counsel and Corporate Secretary
Total Cash $885,389 Equity $1,350,010 Other $20,377 Total Compensation $2,255,776
Kolleen T. Kennedy
President, Proton Solution and Chief Growth Officer
Total Cash $1,425,611 Equity $2,099,989 Other $20,679 Total Compensation $3,546,279
Gary E. Bischoping
Senior Vice President, Finance and Chief Financial Officer
Total Cash $1,014,566 Equity $1,550,036 Other $11,992 Total Compensation $2,576,594
Christopher A. Toth
President, Varian Oncology Systems
Total Cash $954,559 Equity $1,249,998 Other $18,420 Total Compensation $2,222,977
For its 2019 fiscal year, VARIAN MEDICAL SYSTEMS INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Dow R. Wilson CEO Pay $9,446,296 Median Employee Pay $109,548 CEO Pay Ratio 86:1
For its 2019 fiscal year, VARIAN MEDICAL SYSTEMS INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Anat Ashkenazi Total Cash $276,809
David J. Illingworth Total Cash $256,996
Jean-Luc Butel Total Cash $272,621
Jeffrey Balser Total Cash $321,195
Judy Bruner Total Cash $281,246
Phillip Febbo Total Cash $25,000
R. Andrew Eckert Total Cash $371,996
Regina Dugan Total Cash $265,746
Susan L. Bostrom Total Cash $43,000
Timothy E. Guertin Total Cash $246,246

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.